 Silvania Da Silva Teixeira
Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Triiodothyronine | 9 | 2026 | 54 | 1.370 |
Why?
| | Iodide Peroxidase | 1 | 2026 | 35 | 0.930 |
Why?
| | Phosphatidylinositol 3-Kinases | 4 | 2020 | 380 | 0.770 |
Why?
| | Myocytes, Cardiac | 1 | 2026 | 538 | 0.670 |
Why?
| | Calcitriol | 1 | 2020 | 57 | 0.620 |
Why?
| | Vitamins | 1 | 2020 | 176 | 0.570 |
Why?
| | Myocardial Infarction | 1 | 2026 | 1209 | 0.540 |
Why?
| | Insulin | 8 | 2026 | 2500 | 0.530 |
Why?
| | Thyroid Hormones | 3 | 2026 | 68 | 0.530 |
Why?
| | Diiodothyronines | 1 | 2016 | 2 | 0.500 |
Why?
| | Insulin Resistance | 4 | 2016 | 1240 | 0.430 |
Why?
| | Glucose Transporter Type 4 | 3 | 2014 | 39 | 0.410 |
Why?
| | Glucose | 5 | 2026 | 1033 | 0.380 |
Why?
| | Neurons | 2 | 2020 | 1637 | 0.350 |
Why?
| | Receptors, Calcitriol | 2 | 2022 | 55 | 0.340 |
Why?
| | Symporters | 2 | 2016 | 48 | 0.330 |
Why?
| | Blood Glucose | 3 | 2026 | 2326 | 0.280 |
Why?
| | Receptors, Thyroid Hormone | 2 | 2008 | 18 | 0.270 |
Why?
| | Gastrectomy | 2 | 2026 | 161 | 0.260 |
Why?
| | Sodium Iodide | 1 | 2016 | 3 | 0.240 |
Why?
| | Mice, Inbred C57BL | 5 | 2026 | 5954 | 0.240 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 181 | 0.230 |
Why?
| | Glucagon | 1 | 2026 | 114 | 0.220 |
Why?
| | Animals | 16 | 2026 | 37800 | 0.220 |
Why?
| | Glycogen Synthase Kinase 3 | 2 | 2017 | 81 | 0.220 |
Why?
| | Valerates | 1 | 2014 | 3 | 0.210 |
Why?
| | RNA, Messenger | 3 | 2012 | 2808 | 0.200 |
Why?
| | Obesity | 3 | 2025 | 3068 | 0.200 |
Why?
| | Signal Transduction | 5 | 2026 | 5182 | 0.200 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 207 | 0.190 |
Why?
| | Eating | 1 | 2025 | 388 | 0.190 |
Why?
| | Proinsulin | 1 | 2012 | 51 | 0.190 |
Why?
| | Glucose Transporter Type 3 | 1 | 2012 | 15 | 0.180 |
Why?
| | Muscle, Skeletal | 3 | 2016 | 1784 | 0.180 |
Why?
| | Glucose Transporter Type 1 | 1 | 2012 | 49 | 0.180 |
Why?
| | Rats | 8 | 2017 | 5553 | 0.170 |
Why?
| | Hypoglycemia | 1 | 2026 | 479 | 0.170 |
Why?
| | Mice, Knockout | 2 | 2026 | 3106 | 0.170 |
Why?
| | Mice | 6 | 2026 | 18218 | 0.170 |
Why?
| | Glucose Intolerance | 1 | 2022 | 142 | 0.160 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2012 | 214 | 0.160 |
Why?
| | Cell Line | 3 | 2020 | 2821 | 0.160 |
Why?
| | Trans-Activators | 1 | 2012 | 397 | 0.160 |
Why?
| | Dietary Supplements | 1 | 2014 | 575 | 0.160 |
Why?
| | Rats, Long-Evans | 1 | 2020 | 127 | 0.150 |
Why?
| | Weight Loss | 1 | 2025 | 838 | 0.150 |
Why?
| | Gene Expression Regulation | 2 | 2014 | 2589 | 0.150 |
Why?
| | Transcription, Genetic | 1 | 2016 | 1465 | 0.150 |
Why?
| | Hypothalamus | 1 | 2020 | 160 | 0.150 |
Why?
| | Homeodomain Proteins | 1 | 2012 | 523 | 0.140 |
Why?
| | Mice, Transgenic | 2 | 2021 | 2177 | 0.140 |
Why?
| | RANK Ligand | 1 | 2008 | 27 | 0.140 |
Why?
| | Bone Resorption | 1 | 2008 | 81 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2008 | 76 | 0.130 |
Why?
| | Osteoblasts | 1 | 2008 | 146 | 0.130 |
Why?
| | Hep G2 Cells | 1 | 2016 | 74 | 0.120 |
Why?
| | Enzyme Activation | 3 | 2017 | 762 | 0.120 |
Why?
| | Adipose Tissue | 2 | 2016 | 643 | 0.120 |
Why?
| | Male | 10 | 2026 | 72263 | 0.120 |
Why?
| | Neurodegenerative Diseases | 1 | 2017 | 150 | 0.110 |
Why?
| | Glucagon-Like Peptide-1 Receptor | 2 | 2026 | 88 | 0.110 |
Why?
| | Diet, High-Fat | 1 | 2016 | 261 | 0.110 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2016 | 435 | 0.110 |
Why?
| | Estrogens | 1 | 2008 | 364 | 0.110 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 400 | 0.110 |
Why?
| | Congenital Hypothyroidism | 1 | 2004 | 10 | 0.110 |
Why?
| | Rats, Wistar | 3 | 2017 | 445 | 0.100 |
Why?
| | Iodides | 1 | 2014 | 10 | 0.100 |
Why?
| | Phosphorylation | 4 | 2014 | 1702 | 0.100 |
Why?
| | Hypothyroidism | 1 | 2004 | 67 | 0.100 |
Why?
| | Thyroid Gland | 1 | 2014 | 88 | 0.100 |
Why?
| | Peptide Initiation Factors | 1 | 2012 | 16 | 0.090 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2012 | 33 | 0.090 |
Why?
| | Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2012 | 36 | 0.090 |
Why?
| | Hippocampus | 1 | 2017 | 964 | 0.090 |
Why?
| | Energy Metabolism | 1 | 2016 | 925 | 0.080 |
Why?
| | Homeostasis | 2 | 2025 | 635 | 0.080 |
Why?
| | Biotinylation | 2 | 2014 | 37 | 0.070 |
Why?
| | Cell Membrane | 2 | 2012 | 704 | 0.070 |
Why?
| | Brain | 1 | 2021 | 2929 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 461 | 0.070 |
Why?
| | Reactive Oxygen Species | 2 | 2016 | 601 | 0.070 |
Why?
| | Cytokines | 1 | 2016 | 2043 | 0.070 |
Why?
| | Insulin-Secreting Cells | 1 | 2012 | 388 | 0.070 |
Why?
| | PAX8 Transcription Factor | 1 | 2016 | 4 | 0.060 |
Why?
| | Gene Expression | 2 | 2021 | 1474 | 0.060 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2016 | 9 | 0.060 |
Why?
| | Cell Line, Tumor | 3 | 2012 | 3520 | 0.060 |
Why?
| | Mannitol | 1 | 2025 | 40 | 0.060 |
Why?
| | Postprandial Period | 1 | 2026 | 114 | 0.060 |
Why?
| | Thyrotropin | 1 | 2016 | 118 | 0.060 |
Why?
| | Vagus Nerve | 1 | 2025 | 90 | 0.060 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2025 | 146 | 0.050 |
Why?
| | Down-Regulation | 1 | 2016 | 613 | 0.050 |
Why?
| | Female | 4 | 2026 | 78137 | 0.050 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2014 | 339 | 0.050 |
Why?
| | Glucose Tolerance Test | 1 | 2014 | 359 | 0.050 |
Why?
| | Cycloheximide | 1 | 2012 | 42 | 0.050 |
Why?
| | Dactinomycin | 1 | 2012 | 23 | 0.050 |
Why?
| | Nucleic Acid Synthesis Inhibitors | 1 | 2012 | 16 | 0.050 |
Why?
| | Neoplasm Proteins | 1 | 2016 | 440 | 0.050 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2012 | 72 | 0.050 |
Why?
| | Cell Nucleus | 1 | 2016 | 591 | 0.050 |
Why?
| | Protein Synthesis Inhibitors | 1 | 2012 | 48 | 0.050 |
Why?
| | Humans | 5 | 2026 | 144298 | 0.050 |
Why?
| | Bariatric Surgery | 1 | 2026 | 245 | 0.050 |
Why?
| | Deoxyglucose | 1 | 2012 | 49 | 0.040 |
Why?
| | Blotting, Western | 1 | 2014 | 1160 | 0.040 |
Why?
| | Blotting, Northern | 1 | 2011 | 203 | 0.040 |
Why?
| | Polyadenylation | 1 | 2011 | 41 | 0.040 |
Why?
| | Thyroidectomy | 1 | 2011 | 91 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2016 | 1244 | 0.040 |
Why?
| | Mice, Inbred ICR | 1 | 2021 | 113 | 0.040 |
Why?
| | Brain Chemistry | 1 | 2021 | 116 | 0.040 |
Why?
| | Protein Transport | 1 | 2011 | 436 | 0.040 |
Why?
| | Vitamin D | 1 | 2022 | 400 | 0.040 |
Why?
| | Electrophoresis, Agar Gel | 1 | 2008 | 25 | 0.030 |
Why?
| | Osteoclasts | 1 | 2008 | 54 | 0.030 |
Why?
| | Thyroxine | 1 | 2017 | 65 | 0.030 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2017 | 151 | 0.030 |
Why?
| | Alloxan | 1 | 2016 | 4 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 971 | 0.030 |
Why?
| | Liver | 1 | 2014 | 1884 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2012 | 4102 | 0.030 |
Why?
| | Inflammasomes | 1 | 2016 | 145 | 0.030 |
Why?
| | Cell Survival | 1 | 2017 | 1092 | 0.030 |
Why?
| | Anions | 1 | 2014 | 31 | 0.030 |
Why?
| | Superoxides | 1 | 2014 | 199 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2016 | 503 | 0.020 |
Why?
| | Insulinoma | 1 | 2012 | 28 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 388 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2014 | 819 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2008 | 2033 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2012 | 335 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2012 | 454 | 0.020 |
Why?
| | Protein Biosynthesis | 1 | 2012 | 454 | 0.020 |
Why?
| | Oxygen | 1 | 2014 | 978 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 733 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2012 | 2012 | 0.020 |
Why?
| | Pregnancy | 1 | 2021 | 7112 | 0.020 |
Why?
| | Mitochondria | 1 | 2014 | 981 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2012 | 919 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4525 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2016 | 11713 | 0.010 |
Why?
| | Middle Aged | 1 | 2008 | 35892 | 0.010 |
Why?
|
|
Da Silva Teixeira's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|